Practical issues in CAR T-cell therapy

Chimeric antigen receptor (CAR) T-cell therapy presents a revolutionary advancement in personalized cancer treatment. During the production process, the patient's own T-cells are genetically engineered to express a synthetic receptor that binds to a tumor antigen. CAR T-cells are then expanded...

Descripción completa

Detalles Bibliográficos
Autor principal: Byun, Ja Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10133847/
https://www.ncbi.nlm.nih.gov/pubmed/36843380
http://dx.doi.org/10.5045/br.2023.2023015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10133847/
https://www.ncbi.nlm.nih.gov/pubmed/36843380
http://dx.doi.org/10.5045/br.2023.2023015

Ejemplares similares